Status:
UNKNOWN
The Effect of a Sub-symptom Threshold Aerobic Exercise Program on Recovery in Concussed Athletes
Lead Sponsor:
Rocky Mountain University of Health Professions
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
Concussion, Mild
Rehabilitation
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled trial is to examine whether systematic sub-threshold exercise is effective in improving recovery time in athletes after sport related concussion (SRC) compare...
Detailed Description
For this randomized controlled trial, a random number generator will be used to randomly assign subjects to either the Placebo/Stretching group or the Exercise group. Study physicians will be blinded ...
Eligibility Criteria
Inclusion
- are aged 13-17, years and a high school student-athlete who attends school where an athletic trainer can supervise the exercise protocol;
- have sustained a concussion within 2-7 days of clinic presentation and diagnosed by a study physician;
- demonstrate symptom exacerbation during a graded treadmill exercise test and cannot complete the test;
- are currently participating in a school or club sport;
- are English speaking and capable of giving assent
Exclusion
- have a reported history of neurological condition or disorder including but not limited to brain surgery, special education, seizure disorder, speech pathology, previous diagnosis of Post-Concussion Syndrome (PCS),
- are unwilling to exercise,
- have focal neurologic deficit that would represent risk for walking/running on treadmill,
- exhibit an inability to exercise due to injury, known heart disease, or increased cardiac risk,
- have experienced more than 3 previous concussions,
- have suffered a substantial comorbidity (eg,cervical injury),
- currently taking β-blockers, calcium channel blockers, or prophylactic headache medications (e.g., amitriptyline, topiramate), or
- have a resting blood pressure of \> 140/90.
- If the potential participant or parent/guardian is unable to fully understand the study protocol or study risks due to injury or developmental delay, the potential participant will be excluded from the study.
Key Trial Info
Start Date :
February 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03865433
Start Date
February 27 2019
End Date
July 1 2020
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University
Portland, Oregon, United States, 97219